QuickWell Diagnostics isn’t built around one test; it’s built around QuickBind™, our in-house antibody scout that operates somewhere between a chess engine and a truffle-hunting dog. While today’s spotlight is on Fungo-our triple-fungus lateral-flow assay. QuickBind™ is busy mapping the next dozen diagnostics before our coffee reaches RT.

Think of QuickBind™ as the quietly competitive colleague who always has a Plan B (and C). It sifts through protein space at a speed that makes standard wet-lab schedules look positively Victorian, handing our scientists ready-to-build blueprints instead of “interesting leads.” The result: diagnostics that move from whiteboard to working prototype in weeks, not seasons.

Our aim is simple: put reliable answers on the clinician’s bench faster than everyday logistics can slow them down. Fungi first, sepsis next, and so on until “waiting for results” is something people only mention in history podcasts.

-QuickBind™ is busy mapping the next dozen diagnostics before our coffee reaches RT

Our Team

Rohit Kolora

AI/ML Omics

Narayan Sastri Palla

Antibody Engineering

Farzam Gorouhi

CSO

Clinical Diagnostics

Kanika Sharma

CEO

Molecular Diagnostics